Toggle navigation
About
Abstract
Editorial Board
Publication Schedule
Subscription & Newsletter
Contact
Issue
24-4
Table of Contents
Editors Selection
Glaucoma Dialogue
Glaucoma Opinion
Abstracts
Abstracts
Abstracted Journals
Classification List
Index of Authors
Search
Home
Abstracts
Index of Authors
Author #38575
advertisement
Fan S
39
Showing records 1 to 25 |
Display all abstracts from
Fan S
117099
Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial
Feng H
Translational vision science & technology
2024; 13: 21
117826
Xiaoqing: A Q&A model for glaucoma based on LLMs
Xue X
Computers in Biology and Medicine
2024; 174: 108399
118704
NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs
Galli C
Journal of Ocular Pharmacology and Therapeutics
2024; 40: 389-396
116773
Phacogoniotomy versus phacotrabeculectomy for advanced primary angle-closure glaucoma with cataract: A randomized non-inferiority trial
Song Y; Lin F
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2024; 13: 100033
117826
Xiaoqing: A Q&A model for glaucoma based on LLMs
Zhang D
Computers in Biology and Medicine
2024; 174: 108399
117099
Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial
Han D
Translational vision science & technology
2024; 13: 21
118704
NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs
Bastia E
Journal of Ocular Pharmacology and Therapeutics
2024; 40: 389-396
117826
Xiaoqing: A Q&A model for glaucoma based on LLMs
Sun C
Computers in Biology and Medicine
2024; 174: 108399
117099
Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial
Lu W
Translational vision science & technology
2024; 13: 21
116773
Phacogoniotomy versus phacotrabeculectomy for advanced primary angle-closure glaucoma with cataract: A randomized non-inferiority trial
Lv A
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2024; 13: 100033
118704
NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs
Hubatsch DA; Toris C
Journal of Ocular Pharmacology and Therapeutics
2024; 40: 389-396
117826
Xiaoqing: A Q&A model for glaucoma based on LLMs
Shi Y
Computers in Biology and Medicine
2024; 174: 108399
117099
Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial
Tang G
Translational vision science & technology
2024; 13: 21
116773
Phacogoniotomy versus phacotrabeculectomy for advanced primary angle-closure glaucoma with cataract: A randomized non-inferiority trial
Lu L
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2024; 13: 100033
118704
NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs
Fan S
Journal of Ocular Pharmacology and Therapeutics
2024; 40: 389-396
117099
Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial
Zhang H
Translational vision science & technology
2024; 13: 21
117826
Xiaoqing: A Q&A model for glaucoma based on LLMs
Wang R; Tan T
Computers in Biology and Medicine
2024; 174: 108399
116773
Phacogoniotomy versus phacotrabeculectomy for advanced primary angle-closure glaucoma with cataract: A randomized non-inferiority trial
Xie L
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2024; 13: 100033
117099
Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial
Fan S
Translational vision science & technology
2024; 13: 21
118704
NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs
Unser A; Ahmed F
Journal of Ocular Pharmacology and Therapeutics
2024; 40: 389-396
117099
Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial
Lv A
Translational vision science & technology
2024; 13: 21
117826
Xiaoqing: A Q&A model for glaucoma based on LLMs
Gao P
Computers in Biology and Medicine
2024; 174: 108399
116773
Phacogoniotomy versus phacotrabeculectomy for advanced primary angle-closure glaucoma with cataract: A randomized non-inferiority trial
Tang G
Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
2024; 13: 100033
118704
NCX 470 Reduces Intraocular Pressure More Effectively Than Lumigan in Dogs and Enhances Conventional and Uveoscleral Outflow in Non-Human Primates and Human Trabecular Meshwork/Schlemm's Canal Constructs
Torrejon KY
Journal of Ocular Pharmacology and Therapeutics
2024; 40: 389-396
117099
Efficacy of Morning Versus Evening Latanoprost/Timolol Fixed Combination for Open-Angle Glaucoma and Ocular Hypertension: A Randomized Clinical Trial
Jiang J
Translational vision science & technology
2024; 13: 21
«
1
2
»
Issue
24-4
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement